These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacy program for improved handling of antineoplastic agents. Scott SA; Schrott DB; Loesch GA Am J Hosp Pharm; 1983 Jul; 40(7):1179-82. PubMed ID: 6881156 [TBL] [Abstract][Full Text] [Related]
4. Procedures for handling antineoplastic injections in comprehensive cancer centers. LeRoy ML; Roberts MJ; Theisen JA Am J Hosp Pharm; 1983 Apr; 40(4):601-3. PubMed ID: 6846366 [TBL] [Abstract][Full Text] [Related]
6. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk. Sauerland C; Engelking C; Wickham R; Corbi D Oncol Nurs Forum; 2006 Nov; 33(6):1134-41. PubMed ID: 17149396 [TBL] [Abstract][Full Text] [Related]
7. Antineoplastic admixture service in a tertiary-care hospital. Friedman TS; Triboletti M; Sandusky RM; Katz S Am J Hosp Pharm; 1984 Oct; 41(10):2037-44. PubMed ID: 6496492 [TBL] [Abstract][Full Text] [Related]
8. Veterans Administration medical center policies and procedures for handling injectable antineoplastic drugs. Moody DG Am J Hosp Pharm; 1984 May; 41(5):916-9. PubMed ID: 6731452 [TBL] [Abstract][Full Text] [Related]
9. Preparation of guidelines for the avoidance and treatment of extravasation due to antineoplastic drugs. Wolfe CA; Linkewich JA Hosp Pharm; 1987 Feb; 22(2):125-31. PubMed ID: 10280297 [TBL] [Abstract][Full Text] [Related]